Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yingcai Yan"'
Autor:
Jiarong Zhou, Linshi Zhang, Huilin Zheng, Wenhao Ge, Yu Huang, Yingcai Yan, Xiaohu Zhou, Wei Zhu, Yang Kong, Yuan Ding, Weilin Wang
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Abstract Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer ce
Externí odkaz:
https://doaj.org/article/df25b615a550416794146ecdaeb94d30
Autor:
Jiarong Zhou, Wenzhe Wang, Biwen Lei, Wenhao Ge, Yu Huang, Linshi Zhang, Yingcai Yan, Dongkai Zhou, Yuan Ding, Jian Wu, Weilin Wang
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
With the increasing daily workload of physicians, computer-aided diagnosis (CAD) systems based on deep learning play an increasingly important role in pattern recognition of diagnostic medical images. In this paper, we propose a framework based on hi
Externí odkaz:
https://doaj.org/article/d5dc5cd04ec4494a9924953d49957694
Publikováno v:
World Journal of Gastroenterology
Gastrointestinal stromal tumors (GIST), which is the most common mesenchymal tumor of the digestive tract, account for 1%-3% of gastrointestinal tumors. Primary stromal tumors outside the gastrointestinal tract are collectively referred to as extra G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b29d398ee60a7e85b1aca67a41a7a4a
https://doi.org/10.3748/wjg.v26.i40.6195
https://doi.org/10.3748/wjg.v26.i40.6195
Autor:
Xiaohu Zhou, Yang Kong, Yingcai Yan, Wenhao Ge, Yu Huang, Wei Zhu, Weilin Wang, Linshi Zhang, Jiarong Zhou, Yuan Ding, Huilin Zheng
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Cancer Medicine, Vol 9, Iss 3, Pp 1115-1130 (2020)
Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer cells to ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effa5f12de0a3f2184510de16302deef
http://europepmc.org/articles/PMC6997050
http://europepmc.org/articles/PMC6997050
Autor:
Yang Kong, Huilin Zheng, Yuan Ding, Weilin Wang, Hao Xu, Linshi Zhang, Jiarong Zhou, Rong Du, Quan Zhou, Xiaohu Zhou, Yingcai Yan, Shiqi Hu, Yu Huang, Wenhao Ge, Youqing Shen
Publikováno v:
Cancer Letters. 465:36-44
Irinotecan (CPT-11) is an anti-tumor drug and formulated as nanomedicines to reduce side effects and improve efficacy. In vivo, CPT-11 must be hydrolyzed by carboxylesterase to its active form 7-ethyl-10-hydroxycamptothecin (SN-38) to exert anti-tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1faca0580279412ced146e0f053ecb8b
https://doi.org/10.1016/j.canlet.2019.08.019
https://doi.org/10.1016/j.canlet.2019.08.019
Autor:
Jiarong Zhou, Weilin Wang, Xiaohui Qian, Yingcai Yan, Yu Huang, Hao Xu, Linshi Zhang, Wenhao Ge, Xiaohu Zhou
Publikováno v:
OncoTargets and Therapy. 12:1691-1703
Purpose Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis and limited therapeutic options. Ras-related associated with diabetes (RRAD) belongs to the subfamily of Ras-related GTPases and is associated with several types of can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54091a6fe179357874d7fe386a4555b5
https://doi.org/10.2147/ott.s197844
https://doi.org/10.2147/ott.s197844
GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
Autor:
Hao Xu, Jiarong Zhou, Wenhao Ge, Xiaohui Qian, Mugahed Albahde, Weilin Wang, Yingcai Yan, Linshi Zhang, Xiaohu Zhou
Publikováno v:
Experimental and Therapeutic Medicine
Pancreatic cancer is a common malignancy that has a poor prognosis and limited therapeutic options. Enhancer of zeste homolog 2 (EZH2) serves a key role in the progression of different types of cancers. The effect of GSK343 (a competitive inhibitor o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f04a8f1dbdf27f394720e60f129a1f2
https://doi.org/10.3892/etm.2019.7845
https://doi.org/10.3892/etm.2019.7845
Autor:
Yingcai Yan1, Minjie Xie1, Linshi Zhang1, Xiaohu Zhou1, Haiyang Xie1, Lin Zhou1, Shusen Zheng2,3 shusenzheng@zju.edu.cn, Weilin Wang2,3 wam@zju.edu.cn
Publikováno v:
OncoTargets & Therapy. Jun2016, Vol. 9, p3925-3937. 13p.
Autor:
Haiyang Xie, Weilin Wang, Linshi Zhang, Yingcai Yan, Xiaohu Zhou, Minjie Xie, Shusen Zheng, Lin Zhou
Publikováno v:
OncoTargets and therapy
Yingcai Yan,1,* Minjie Xie,1,* Linshi Zhang,1 Xiaohu Zhou,1 Haiyang Xie,1 Lin Zhou,1 Shusen Zheng,2,3 Weilin Wang2,31Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, College of Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d2f4645ee9d2fa7424a8d47fc566c9
https://doi.org/10.2147/ott.s106703
https://doi.org/10.2147/ott.s106703
Autor:
Yingcai Yan, Haiyang Xie, Bichun Zheng, Shusen Zheng, Linshi Zhang, Yuan Zhang, Lin Zhou, Weilin Wang, Xiaohu Zhou
Publikováno v:
Cancer Science
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third leading cause of cancer-related deaths worldwide. The fate of a cell is determined by the balance between the processes of fission and fusion that constantly occur in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b944b6374ed3909a389b34db838b3962
http://europepmc.org/articles/PMC4832850
http://europepmc.org/articles/PMC4832850